A study to investigate the safety and efficacy of AMX0035 in patients with Amyotrophic Lateral Sclerosis A study to investigate the safety and efficacy of AMX0035 in patients with Amyotrophic Lateral Scler ...
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of AMX0035 Versus Placebo for 48-week Treatment of Adult Patients with Amyotrophic Lateral Sclerosis (ALS) - Phoenix A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety ...
ALS (amyotrophic lateral sclerosis) MedDRA version: 21.1;Level: PT;Classification code 10002026;Term: Amyotrophic lateral sclerosis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] ALS (amyotrophic lateral sclerosis) MedDRA version: 21.1;Level: PT;Classification code 10002026;Term ...
Product Code: AMX0035 INN or Proposed INN: fenilbutirato INN or Proposed INN: Ursodoxicoltaurina Other descriptive name: taurursodiol Product Code: AMX0035 INN or Proposed INN: Fenilbutirato INN or Proposed INN: Ursodoxicoltaurina Other descriptive name: taurursodiol Product Code: AMX0035 INN or Proposed INN: fenilbutirato INN or Proposed INN: Ursodoxicoltaurina Other ...